NASDAQ:ADUS Addus HomeCare (ADUS) Stock Forecast, Price & News $85.72 +0.06 (+0.07%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$85.66▼$86.9550-Day Range$82.88▼$96.3052-Week Range$77.30▼$114.99Volume56,227 shsAverage Volume76,969 shsMarket Capitalization$1.39 billionP/E Ratio25.90Dividend YieldN/APrice Target$110.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Addus HomeCare MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside28.9% Upside$110.50 Price TargetShort InterestHealthy1.80% of Shares Sold ShortDividend StrengthN/ASustainability-0.50Upright™ Environmental ScoreNews Sentiment1.08Based on 3 Articles This WeekInsider TradingSelling Shares$3.28 M Sold Last QuarterProj. Earnings Growth11.64%From $3.78 to $4.22 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.98 out of 5 starsMedical Sector32nd out of 967 stocksHome Health Care Services Industry3rd out of 7 stocks 3.5 Analyst's Opinion Consensus RatingAddus HomeCare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $110.50, Addus HomeCare has a forecasted upside of 28.9% from its current price of $85.72.Amount of Analyst CoverageAddus HomeCare has only been the subject of 3 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted1.80% of the outstanding shares of Addus HomeCare have been sold short.Short Interest Ratio / Days to CoverAddus HomeCare has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Addus HomeCare has recently decreased by 2.08%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldAddus HomeCare does not currently pay a dividend.Dividend GrowthAddus HomeCare does not have a long track record of dividend growth. Previous Next 5.0 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreAddus HomeCare has received a 85.99% net impact score from Upright. The largest positive contribution comes from its "Meaning & joy" impact, which is mostly driven by its "Private hospice care", "Private occupational therapy services", and "Private home care for the elderly" products. See details.Environmental SustainabilityThe Environmental Impact score for Addus HomeCare is -0.50. Previous Next 2.8 News and Social Media Coverage News SentimentAddus HomeCare has a news sentiment score of 1.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Addus HomeCare this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for ADUS on MarketBeat in the last 30 days. This is a decrease of -83% compared to the previous 30 days.MarketBeat Follows1 people have added Addus HomeCare to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Addus HomeCare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,279,405.00 in company stock.Percentage Held by InsidersOnly 4.40% of the stock of Addus HomeCare is held by insiders.Percentage Held by Institutions95.26% of the stock of Addus HomeCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Addus HomeCare are expected to grow by 11.64% in the coming year, from $3.78 to $4.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Addus HomeCare is 25.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.54.Price to Earnings Ratio vs. SectorThe P/E ratio of Addus HomeCare is 25.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 102.74.Price to Earnings Growth RatioAddus HomeCare has a PEG Ratio of 1.79. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAddus HomeCare has a P/B Ratio of 2.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Addus HomeCare (NASDAQ:ADUS) StockAddus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Read More ADUS Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ADUS Stock News HeadlinesSeptember 19, 2023 | stocknews.com3 Medical Stocks Generating Buzz Among InvestorsSeptember 18, 2023 | stocknews.comWall Street Buys: 3 'A' Rated Medical StocksSeptember 23, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.September 17, 2023 | americanbankingnews.comAddus HomeCare Co. (NASDAQ:ADUS) Receives $110.50 Consensus Price Target from AnalystsSeptember 16, 2023 | seekingalpha.comAddus HomeCare: More Challenges To Think About With CMS ProposalsAugust 22, 2023 | finance.yahoo.comWhat Is Addus HomeCare Corporation's (NASDAQ:ADUS) Share Price Doing?August 3, 2023 | msn.comStephens & Co. Maintains Addus HomeCare (ADUS) Overweight RecommendationAugust 2, 2023 | finance.yahoo.comAddus HomeCare Corp (ADUS): A Healthcare Provider with High Outperformance PotentialSeptember 23, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.August 1, 2023 | markets.businessinsider.comThe Latest Analyst Ratings for Addus HomeCareAugust 1, 2023 | finance.yahoo.comAddus HomeCare Completes Acquisition of Tennessee Quality Care OperationsJuly 31, 2023 | finance.yahoo.comAddus HomeCare Announces Second Quarter 2023 Financial ResultsJuly 31, 2023 | finance.yahoo.comAddus HomeCare (ADUS) Q2 Earnings and Revenues Beat EstimatesJuly 23, 2023 | finance.yahoo.comAddus HomeCare's (NASDAQ:ADUS) Returns Have Hit A WallJuly 20, 2023 | finance.yahoo.comWhy Addus HomeCare (ADUS) Could Beat Earnings Estimates AgainJuly 17, 2023 | finance.yahoo.comAddus HomeCare Announces Second Quarter 2023 Earnings Release and Conference CallJuly 1, 2023 | msn.comAddus HomeCare: Economic Troubles Remain Well In Situ, Reiterate HoldJune 29, 2023 | markets.businessinsider.comAnalyst Expectations for Addus HomeCare's FutureJune 29, 2023 | finance.yahoo.comAddus HomeCare Expands Tennessee Home Care Presence With Agreement to Acquire Tennessee Quality Care OperationsJune 6, 2023 | finance.yahoo.comThermo Fisher's (TMO) Unveils Orbitrap Astral SpectrometerMay 29, 2023 | msn.comWall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should KnowMay 29, 2023 | finance.yahoo.comWall Street Analysts Predict a 28.56% Upside in Addus HomeCare (ADUS): Here's What You Should KnowMay 27, 2023 | msn.comOppenheimer Reiterates Addus HomeCare (ADUS) Outperform RecommendationMay 26, 2023 | markets.businessinsider.comOppenheimer Keeps Their Buy Rating on Addus Homecare (ADUS)May 26, 2023 | finance.yahoo.comMedtronic (MDT) to Expand Diabetes Care With New BuyoutMay 26, 2023 | fool.comAddus HomeCare (NASDAQ: ADUS)May 25, 2023 | finance.yahoo.comInvestors in Addus HomeCare (NASDAQ:ADUS) have seen favorable returns of 54% over the past five yearsSee More Headlines Receive ADUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter. Email Address ADUS Company Calendar Last Earnings7/31/2023Today9/23/2023Next Earnings (Estimated)10/30/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Home health care services Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:ADUS CUSIPN/A CIK1468328 Webwww.addus.com Phone(469) 535-8200Fax630-487-2707Employees33,182Year FoundedN/APrice Target and Rating Average Stock Price Forecast$110.50 High Stock Price Forecast$118.00 Low Stock Price Forecast$105.00 Forecasted Upside/Downside+28.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$3.31 Trailing P/E Ratio25.90 Forward P/E Ratio22.68 P/E Growth1.79Net Income$46.03 million Net Margins5.39% Pretax Margin6.92% Return on Equity9.06% Return on Assets6.21% Debt Debt-to-Equity Ratio0.12 Current Ratio1.55 Quick Ratio1.55 Sales & Book Value Annual Sales$951.12 million Price / Sales1.46 Cash Flow$4.17 per share Price / Cash Flow20.56 Book Value$39.33 per share Price / Book2.18Miscellaneous Outstanding Shares16,200,000Free Float15,487,000Market Cap$1.39 billion OptionableOptionable Beta0.86 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. R. Dirk Allison (Age 67)CEO & Chairman Comp: $1.81MMr. W. Bradley Bickham (Age 60)Pres & COO Comp: $942.47kMr. Brian W. Poff (Age 49)CFO, Exec. VP, Sec. & Treasurer Comp: $842.78kMs. Monica Raines (Age 44)Exec. VP and Chief Compliance & Quality Officer Comp: $538.17kMr. Cliff Blessing (Age 43)Exec. VP & Chief Devel. Officer Comp: $478.61kMr. Zach SimpsonSr. VP & Chief Accounting OfficerMr. Michael D. Wattenbarger (Age 53)Exec. VP & Chief Information Officer Mr. Sean P. Gaffney (Age 44)Exec. VP & Chief Legal Officer Mr. Roberton James Stevenson (Age 43)Exec. VP & Chief Human Resource Officer Mr. Darby Anderson (Age 57)Exec. VP & Chief Gov. Relations Officer More ExecutivesKey CompetitorsAdaptHealthNASDAQ:AHCOEnhabitNYSE:EHABAmedisysNASDAQ:AMEDCatalyst PharmaceuticalsNASDAQ:CPRXStructure TherapeuticsNASDAQ:GPCRView All CompetitorsInsiders & InstitutionsBarclays PLCBought 10,102 shares on 9/21/2023Ownership: 0.163%Virginia Retirement Systems ET ALBought 2,200 shares on 8/22/2023Ownership: 0.014%California State Teachers Retirement SystemSold 505 shares on 8/21/2023Ownership: 0.120%Teachers Retirement System of The State of KentuckyBought 281 shares on 8/21/2023Ownership: 0.032%Osaic Holdings Inc.Bought 294 shares on 8/21/2023Ownership: 0.019%View All Insider TransactionsView All Institutional Transactions ADUS Stock - Frequently Asked Questions Should I buy or sell Addus HomeCare stock right now? 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ADUS shares. View ADUS analyst ratings or view top-rated stocks. What is Addus HomeCare's stock price forecast for 2023? 4 Wall Street analysts have issued 12-month target prices for Addus HomeCare's shares. Their ADUS share price forecasts range from $105.00 to $118.00. On average, they predict the company's share price to reach $110.50 in the next year. This suggests a possible upside of 28.9% from the stock's current price. View analysts price targets for ADUS or view top-rated stocks among Wall Street analysts. How have ADUS shares performed in 2023? Addus HomeCare's stock was trading at $99.49 at the start of the year. Since then, ADUS stock has decreased by 13.8% and is now trading at $85.72. View the best growth stocks for 2023 here. When is Addus HomeCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, October 30th 2023. View our ADUS earnings forecast. How were Addus HomeCare's earnings last quarter? Addus HomeCare Co. (NASDAQ:ADUS) announced its quarterly earnings data on Monday, July, 31st. The company reported $0.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.07. The business earned $259.98 million during the quarter, compared to analyst estimates of $255.56 million. Addus HomeCare had a net margin of 5.39% and a trailing twelve-month return on equity of 9.06%. What ETFs hold Addus HomeCare's stock? ETFs with the largest weight of Addus HomeCare (NASDAQ:ADUS) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), Argent Mid Cap ETF (AMID), Invesco S&P SmallCap Health Care ETF (PSCH) and BNY Mellon Women's Opportunities ETF (BKWO).iShares U.S. Healthcare Providers ETF (IHF). What is Dirk Allison's approval rating as Addus HomeCare's CEO? 91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Addus HomeCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS). What is Addus HomeCare's stock symbol? Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS." Who are Addus HomeCare's major shareholders? Addus HomeCare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.88%), Silvercrest Asset Management Group LLC (4.33%), Dimensional Fund Advisors LP (4.05%), Principal Financial Group Inc. (3.94%), State Street Corp (3.49%) and WCM Investment Management LLC (3.17%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham. View institutional ownership trends. How do I buy shares of Addus HomeCare? Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Addus HomeCare's stock price today? One share of ADUS stock can currently be purchased for approximately $85.72. How much money does Addus HomeCare make? Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.39 billion and generates $951.12 million in revenue each year. The company earns $46.03 million in net income (profit) each year or $3.31 on an earnings per share basis. How many employees does Addus HomeCare have? The company employs 33,182 workers across the globe. How can I contact Addus HomeCare? Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707. This page (NASDAQ:ADUS) was last updated on 9/23/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addus HomeCare Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.